Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

NeuPath Health Inc. (V:NPTH)

Business Focus: Healthcare Facilities & Services (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for NPTH within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Mar 15, 2024 07:30 ET
NEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2023 RESULTS
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three months and year ended December 31, 2023. All figures are in Canadian dollars, unless otherwise noted.
Read full article
Jan 15, 2024 07:30 ET
NEUPATH ANNOUNCES CLINIC ACQUISITION
NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the closing of the acquisition of the assets of SIBI Medical Inc., operating as the London Spine Institute in London, Ontario effective January 12, 2024.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.47
--
--
Price to Sales - TTM
0.14
0.78
3.45
Price to Book - most recent quarter
0.42
2.20
2.04
Price to Cash Flow per share - TTM
3.85
9.13
10.35
Price to Free Cash Flow per share - TTM
3.47
13.24
12.34
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jan 31, 202424,00023,846
Jan 15, 2024154-9,796
Dec 31, 20239,9509,890
See Short Report

Business Summary

Sector:  Healthcare Industry:  Healthcare Facilities & Services

NeuPath Health Inc. operates a network of healthcare clinics and related businesses focused on improved access to care and outcomes for patients by leveraging treatments and delivering patient-centered multidisciplinary care. The Company operates a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. It provides workplace health services and independent medical assessments to employers and disability insurers through a national network of healthcare providers, as well as contract research services to pharmaceutical and biotechnology companies. The Company's health care providers cover a range of specialties, which include physiatrists, neurologists, anesthesiologists, general practitioners with specialized training in chronic pain, as well as medication management physicians, athletic therapists, and nurses.

See business summary

 

Twitter

Search (past week) for $NPTH.CA NPTH.V

  • No tweets found